Allogene Therapeutics, Inc. ALLO
- ALLO-715 — Multiple Myeloma
BCMA (5 companies · 5 programs)
Companies with an active program directed at BCMA.
Caribou Biosciences, Inc. CRBU
- CB-011 — Relapsed/Refractory Multiple Myeloma Phase 1
Cullinan Therapeutics, Inc. CGEM
- velinotamig — Systemic Lupus Erythematosus Phase 1
Immix Biopharma, Inc. IMMX
- NXC-201 — Relapsed/Refractory AL Amyloidosis Phase 2
Sana Biotechnology, Inc. SANA
- SG227 — Multiple Myeloma Preclinical